Advanced search    

Search: authors:"Alexander Molassiotis"

6 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Sham Acupressure Controls Used in Randomized Controlled Trials: A Systematic Review and Critique

Objectives To explore the commonly utilized sham acupressure procedures in existing acupressure trials, and to assess whether different types of sham interventions yield different therapeutic outcomes, and, as far as possible, to identify directions for the future development of an adequate sham acupressure method. Methods Randomized controlled trials comparing true acupressure...

Current Evidence on Auricular Therapy for Chemotherapy-Induced Nausea and Vomiting in Cancer Patients: A Systematic Review of Randomized Controlled Trials

drafted and revised this paper. Alexander Molassiotis undertook the study design and critically revised this paper. Tao Wang completed literature searching and data extraction. Lorna K. P. Suen undertook

Adverse Events of Auricular Therapy: A Systematic Review

’ Contribution Jing-Yu Tan undertook the study design, completed the literature searching and data extraction and analysis, and drafted and revised this paper. Alexander Molassiotis undertook the study design and

Antiemetic research: future directions

Purpose and methods As a part of reviewing the Multinational Association of Supportive Care in Cancer (MASCC) antiemetic guidelines in Perugia in 2009, an expert group identified directions for future antiemetic research. Results and conclusions In future trials, the prediction of nausea and vomiting may combine algorithms based on observed prognostic factors relating to the...

Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009

Only a few studies have been carried out in children on the prevention of chemotherapy-induced nausea and vomiting (CINV). 5-HT3 receptor antagonists have been shown to be more efficacious and less toxic than metoclopramide, phenothiazines and cannabinoids. Most dose studies are available for the 5-HT3 receptor antagonists ondansetron and granisetron. The new 5-HT3 receptor...

Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009

Radiation-induced nausea and vomiting (RINV) are still often underestimated by radiation oncologists. However, as many as 50–80% of patients undergoing radiotherapy (RT) will experience nausea and/or vomiting, depending on the site of irradiation. Fractionated RT may involve up to 40 fractions over a 6–8-week period, and prolonged symptoms of nausea and vomiting affect quality of...